{
  "trial_id": "NCT00196742",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Fabry Registry: All patients with a confirmed diagnosis of Fabry disease who have signed the informed consent and patient authorization form(s) are eligible for leukocyte \u03b1GAL (alpha-galactosidase) enzyme activity and/or mutation(s) in the gene coding for \u03b1GAL.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Fabry Pregnancy Sub-registry: Eligible women must be enrolled in the Fabry Registry. be pregnant, or have been pregnant with appropriate medical documentation available. provide a signed informed consent and authorization form(s) to participate in the Sub-Registry prior to any Sub-Registry-related data collection being performed.",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [],
  "notes": "The patient is a pregnant woman with fever, chills, nausea, vomiting, dysuria, urgency, frequency, and flank pain. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts.",
  "_meta": {
    "topic_id": "51",
    "trial_id": "NCT00196742",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}